CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy

Nat Commun. 2022 Nov 4;13(1):6646. doi: 10.1038/s41467-022-34222-8.

Abstract

While food allergy oral immunotherapy (OIT) can provide safe and effective desensitization (DS), the immune mechanisms underlying development of sustained unresponsiveness (SU) following a period of avoidance are largely unknown. Here, we compare high dimensional phenotypes of innate and adaptive immune cell subsets of participants in a previously reported, phase 2 randomized, controlled, peanut OIT trial who achieved SU vs. DS (no vs. with allergic reactions upon food challenge after a withdrawal period; n = 21 vs. 30 respectively among total 120 intent-to-treat participants). Lower frequencies of naïve CD8+ T cells and terminally differentiated CD57+CD8+ T cell subsets at baseline (pre-OIT) are associated with SU. Frequency of naïve CD8+ T cells shows a significant positive correlation with peanut-specific and Ara h 2-specific IgE levels at baseline. Higher frequencies of IL-4+ and IFNγ+ CD4+ T cells post-OIT are negatively correlated with SU. Our findings provide evidence that an immune signature consisting of certain CD8+ T cell subset frequencies is potentially predictive of SU following OIT.

Publication types

  • Randomized Controlled Trial
  • Clinical Trial, Phase II
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Allergens
  • Arachis
  • CD8-Positive T-Lymphocytes
  • Cell Differentiation
  • Desensitization, Immunologic / methods
  • Feasibility Studies
  • Immunoglobulin E
  • Immunologic Factors
  • Peanut Hypersensitivity* / therapy

Substances

  • Immunoglobulin E
  • Allergens
  • Immunologic Factors